Literature DB >> 30014678

[Clinical curative effect research status and analysis of acupuncture treatment for primary insomnia].

Ying Li1, Xiaoyang Zhang1, Fei Bao1, Aijun Sun2.   

Abstract

OBJECTIVE: To grasp the clinical efficacy of acupuncture in the treatment of primary insomnia (PI), and analyze its future research directions.
METHODS: A total of 41 prospective randomized controlled trials (RCTs) were conducted in which the clinical efficacy of acupuncture for treatment of PI was compared with sedative and hypnotic drugs in recent six years by searching databases of CNKI, WANFANG database, PubMed, and BioMed Central (BMC), the aspects of diagnostic criteria, efficacy standards, observation time, control drugs, characteristics of acupoint selection and regularity were used to review and analyse.
RESULTS: Acupuncture treatment for PI was mainly based on acupoints in the head, combined with selecting the points according to the different syndrome, showing short-term efficacy and safety advantages, but it was not well-established in many aspects such as diagnostic criteria, efficacy evaluation, observation time, and control drugs.
CONCLUSION: Current evidence shows that acupuncture treatment is effective, but it is necessary to add more stringent RCTs, and introduce objective monitoring indicators to strengthen the evidence and enhance the overall level of research.

Entities:  

Keywords:  acupuncture; clinical efficacy; database; primary insomnia; review

Mesh:

Year:  2018        PMID: 30014678     DOI: 10.13703/j.0255-2930.2018.07.030

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  1 in total

1.  Assessment of Reporting Quality in Randomized Controlled Trials of Acupuncture for Primary Insomnia with CONSORT Statement and STRICTA Guidelines.

Authors:  Jinsong Yang; Fanjun Yu; Keyi Lin; Haotian Qu; Yihan He; Jing Zhao; Fen Feng; Litao Pan; Yu Kui
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-17       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.